bioRxivPharmacology & ToxicologyPreprint
AMODO-EO: A Practical Framework for Adaptive ObjectiveDiscovery in Multi-Objective Drug Optimization
Abstract
Multi-objective optimization in drug discovery faces a fundamental limitation: the assumption that all relevant optimization criteria can be predefined. Traditional approaches using fixed objective sets often miss critical molecular trade-offs that emerge during the optimization process. We present AMODO-EO (Adaptive Multi-Objective Drug Optimization with Emergent Objectives), a novel framework that systematically discovers, validates, and integrates new optimization criteria during the search process by analyzing chemical data patterns. Building upon established automated feature engineering principles, AMODO-EO extends these techniques to dynamic multi-objective optimization contexts in drug discovery. The framework automatically generates candidate objectives from molecular descriptor relationships, validates them through rigorous statistical independence and variance criteria, and integrates them into the optimization process using adaptive weighting mechanisms. Comprehensive experiments on ChEMBL datasets demonstrate consistent identification of chemically meaningful objectives such as the hydrogen-bond acceptor/rotatable-bond ratio, which captures previously unspecified trade-offs between molecular polarity and flexibility. Statistical validation confirms that discovered objectives are independent of predefined criteria while providing significant discriminative power. Performance analysis shows that AMODO-EO successfully extends multi-objective formulations while maintaining competitive optimization performance on original objectives, with only 2-3% performance cost for the discovery capability. The framework opens new possibilities for adaptive optimization in chemical design by automatically revealing hidden molecular relationships that provide actionable insights for drug designers. Our approach represents a significant advancement in computational drug discovery by transforming multi-objective optimization from a purely exploitative process into one that systematically explores the space of potential optimization criteria.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- AutoLead: An LLM-Guided Bayesian Optimization Framework for Multi-Objective Lead Optimization
Yiming Zhang, Jun Jin Choong, … Keisuke Ozawa·Journal of Chemical Information and ModelingPeer-reviewed·Apr 29, 2026
- A closed-loop language-model agent for target-specific multi-objective hit-to-lead optimization
Wentao Cui, Limeng Tian, … Jiaxin Hu·bioRxiv·Sep 24, 2026
- OptiMol: Optimization of binding affinities in chemical space for drug discovery
Jacques Boitreaud, Vincent Mallet, … Jérôme Waldispühl·Journal of Chemical Information and ModelingPeer-reviewed·Sep 28, 2020
- Nevermore: Target-Conditioned Protein-Ligand Representation Learning for Multi-Objective Lead Optimization with Database-Grounded Retrieval
Mohammad S. Refahi, Milad Amir Toutounchian, … GAIL L. ROSEN·BiologyPeer-reviewed·Jun 21, 2026
- Directed Chemical Evolution via Navigating Molecular Encoding Space
Lin Wang, Yifan Wu, … Yang Zhang·bioRxiv·Mar 18, 2025
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening
Rohan Chandraghatgi, Hai‐Feng Ji, … Bahrad Ali Sokhansanj·Journal of Chemical Information and ModelingPeer-reviewed·May 2, 2024